Identification of a selective inhibitor of IDH2/R140Q enzyme that induces cellular differentiation in leukemia cells

BACKGROUND: IDH2/R140Q mutation is frequently detected in acute myeloid leukemia (AML). It contributes to leukemia via accumulation of oncometabolite D-2-HG. Therefore, mutant IDH2 is a promising target for AML. Discovery of IDH2 mutant inhibitors is in urgent need for AML therapy. METHODS: Structur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jiao, Yang, Jie, Wei, Qingyun, Weng, Ling, Wu, Fei, Shi, Yun, Cheng, Xiaolan, Cai, Xueting, Hu, Chunping, Cao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126369/
https://www.ncbi.nlm.nih.gov/pubmed/32245484
http://dx.doi.org/10.1186/s12964-020-00536-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126369/
https://www.ncbi.nlm.nih.gov/pubmed/32245484
http://dx.doi.org/10.1186/s12964-020-00536-7

Ejemplares similares